Sharepoint Solutions
PRODUCTS
-
Specialist in Aseptic Fill-Finish and packaging of Cartridges, pre-filled syringes (PFS) and vials.
-
Learn how our 4,000-square-foot cGMP manufacturing site is purpose-built to support your microbial program from pre-clinical to commercial manufacturing.
-
AST’s aseptic processing solutions are outfitted with the latest in intuitive cGMP technology designed to optimize the fill-finish process for the highest standards of quality and regulatory compliance.
-
A successful clinical trial starts with an efficient protocol review.
With deep roots in academic research and clinical medicine, BRANY IRB is uniquely positioned to meet your cost and speed requirements. Get your clinical trial to the start line while ensuring participant health and safety.
WHITE PAPERS AND CASE STUDIES
-
Improving Patient Health and Safety: Quality and Analytical Scientist
Explore how an analytical scientist enhanced quality and compliance for a pharmaceutical company by managing complex analytical testing and vendor interactions.
-
Optimal Syringe Carton Design To Meet Drug Manufacturers' Needs
Learn about the advantages of an optimal packaging design and the resulting benefits of its implementation to the overall process.
-
Pioneering Cancer Research Meets Unparalleled Veeva Vault Integration
A biotech company revolutionizing cancer treatment faced delays due to a complex, error-prone document review process. Discover how integrating an innovative strategy transformed their workflow.
-
BioIVT Collaborates With IDBS To Deploy IDBS E-WorkBook And Reduce Study Cycle Times
Learn about a collaboration that has enabled BioIVT to enhance efficiency and responsiveness to its biopharmaceutical clients.
-
Advancing In Silico Predictions In Early Drug Discovery
Examine a high-throughput approach that streamlines LogD measurements, offering faster and more accurate insight into compound lipophilicity to support better decision-making in early drug discovery.
-
Taking Research In-House With CRIO: SciTech's Multi-Center Phase 1 Study
Explore the success story of an early-stage clinical pharmaceutical company that effectively navigated funding constraints when conducting its Phase 1 study without a third-party CRO.
-
PEG In LNP Formulations: Addressing Challenges And Seeking Solutions
Polyethylene glycol and similar variants have driven innovative research for therapies. However, the continued use of PEG poses significant drawbacks.
-
Arkansas, USA | Pulp And Paper Mill
A pulp and paper mill in Arkansas replaced chemical treatments with SDOX systems, resulting in reduced costs, improved odor control, and better water quality. The technology has also shown effectiveness in treating shallow surface waters.
-
How eSource Reduced Benchmark's Protocol Deviations By Almost 40%
Explore how a leading vaccine site network selected CRIO to help address the challenges with it's use of paper charts in collecting source data.
-
Improving Patient Health And Safety: Medical Safety Scientist
See how this experienced safety scientist managed benefit-risk assessments and pharmacovigilance while streamlining product development and lifecycle management for a pharmaceutical company.
-
Digitalizing Batch Records In Pharmaceutical Production
Pharma manufacturing embraces cutting-edge automation, yet outdated paper-based documentation hinders efficiency and delays batch releases. See how digital solutions can transform compliance.
-
Annex 1: Sterile Fill/Finish For Early Phase Clinical Supplies
Meeting stringent requirements for sterile fill/finish operations hinges on robust contamination control strategies, advanced isolator technology, and rigorous integrity testing to ensure patient safety.
NEWS
-
Safeguarding Citrus: International Collaboration Between Australia And Indonesia, Targets Huánglóngbìng Threat6/25/2025
NSW Department of Primary Industries and Regional Development (NSW DPIRD) has reaffirmed its commitment to protecting Australia’s citrus industry through international collaboration against huánglóngbìng (HLB), also known as citrus greening disease.
-
Egetis Therapeutics Initiates New Drug Application In The USA For Emcitate (Tiratricol) For MCT8 Deficiency12/19/2025
Egetis Therapeutics AB (publ) (“Egetis” or the “Company”), today announced that the Company has initiated a rolling New Drug Application (NDA) submission to the U.S. Food and Drug Administration (FDA) for Emcitate (tiratricol), its investigational drug for the treatment of MCT8 deficiency.
-
Rapeseed Protein For Vegan Burger Patties And Nutritious Chicken Feed8/13/2025
Food products containing proteins from plants, fungi or algae are becoming increasingly popular. Researchers at the Fraunhofer Center for Chemical-Biotechnological Processes CBP in Leuna, Germany, have now shown that previously rarely used rapeseed proteins are also a valuable source of protein alternatives: using the EthaNa process, they extract not only high-quality rapeseed oil from rapeseed but also a protein-rich rapeseed kernel concentrate, which can be processed for instance into burger patties and pasta or used as a nutritious feed in poultry fattening.
-
Advancing Regional Polio Vaccine Production With Fixed-Bed Bioreactor Technology4/9/2025
Batavia Biosciences, a leading contract development and manufacturing organization (CDMO), has pioneered a novel upstream bioprocessing method to enhance regional polio vaccine production.
-
The Secret Life Of Catalysts: New Discoveries In Chemical Reactions1/24/2025
Scientists from the Interface Science Department of the Fritz Haber Institute of the Max Planck Society in collaboration with beamline scientists at the Helmholtz-Zentrum Berlin have made an advancement in the field of electrocatalysis.